Your session is about to expire
← Back to Search
Study Summary
This trial looks at how drugs LNZ101 & LNZ100 are absorbed in the body & how long they stay in the system.
- Eye Diseases
- Presbyopia
- Refractive Errors
- Brimonidine Tartrate
- Acetylcholine
- Eye Drops
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- You have any ongoing health condition, either in your whole body or in your eyes, except for vision problems that can be fixed with glasses or contact lenses.You have any eye problems that could affect how well eye drops are absorbed.You have trouble seeing things up close with both of your eyes.
- Group 1: LNZ101
- Group 2: LNZ100
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the age range of this medical trial limited in any way?
"The upper age limit for inclusion in this study is 75 years, while the lower cutoff point sits at 45. For those outside these boundaries, 21 trials are available to participants below 18 and 122 opportunities are open to seniors above 65."
Is this research effort currently recruiting participants?
"According to clinicaltrials.gov, the recruitment phase for this trial has ended as of June 30th 2023; the initial posting being made on July 6th. Notwithstanding, there are presently 144 other trials actively recruiting patients now."
Is it possible for me to join this experiment?
"This clinical trial is limited to 30 patients between 45 and 75 years old who are suffering from eye diseases."
Has the combination of Aceclidine and Brimonidine been sanctioned by the FDA?
"Due to the limited information currently available about Aceclidine + Brimonidine, our team has rated its safety a 1 on a scale of 1-3. This implies that Phase 1 testing is still underway for efficacy and safety assessments."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger